Cases & Deals

Share

Faron Pharmaceuticals completes IPO on AIM

November 2015

Client(s) Faron Pharmaceuticals Oy

Jones Day advised Faron Pharmaceuticals Oy, a clinical stage biopharmaceutical company based in Turku, Finland, in connection with its initial public offering of Ordinary Shares on the Alternative Investment Market (AIM). Cairn Financial Advisors acted as nominated advisor and Whitman Howard Limited acted as nominated broker.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.